[Congressional Record (Bound Edition), Volume 161 (2015), Part 2]
[Senate]
[Pages 1745-1747]
[From the U.S. Government Publishing Office, www.gpo.gov]




                           AMERICAN CURES ACT

  Mr. DURBIN. Mr. President, 3 weeks ago, scientists at Boston's 
Northeastern University made an amazing

[[Page 1746]]

discovery in a pile of dirt. They found a new antibiotic called 
teixobactin. This new antibiotic, the first that has been discovered in 
more than 25 years, holds the potential to kill off a wide variety of 
disease-causing bacteria. It offers hope for a cure to serious and 
growing antibiotic resistant diseases.
  President Obama noted in his State of the Union Address that 
antibiotic resistance is one of the world's most pressing public health 
challenges. In the United States alone, it costs us at least $20 
billion a year and claims 23,000 lives.
  A plastic storage crate filled with backyard dirt might seem like an 
unlikely source for a breakthrough, but that is exactly where these 
scientists--who were working under a grant from the National Institutes 
of Health--discovered this potentially lifesaving medical breakthrough.
  Scientific breakthroughs are nothing new for the United States of 
America. In the last century we split the atom, defeated polio, 
conquered space, created the Internet, and mapped the human genome. All 
of those historic achievements had something in common with the 
discovery of teixobactin--they were backed by U.S. Government research 
funds.
  I have people come up to me in Illinois and say: Name one thing this 
government has ever done. Well, aside from winning a few wars that were 
critical to the future of mankind, we have done amazing things when it 
comes to research.
  For generations the United States was the unchallenged world leader 
in support of scientific research, but in recent years our lead has 
eroded. In 1965 the United States spent 25 percent of our nondefense 
discretionary budget on research and development--1965, 25 percent; 
today, 10 percent.
  Meanwhile, other countries are stepping up. China has increased 
research and development funding by 20 percent a year every year from 
1999 to 2009. If we stay on course, China will be investing more in 
research and development as a share of their overall economy than the 
United States in as soon as 5 years.
  The erosion of U.S. funding is particularly troublesome and costly in 
the area of biomedical research. Thanks to budget cuts, and 
particularly the sequestration, the U.S. share of global biomedical 
research funding declined by 13 percent between 2004 and 2012. 
Lifesaving discoveries are being delayed and young scientists are 
finding fewer funding opportunities. A decade ago 30 percent of the 
qualified NIH grant proposals were funded, today it is just 18 percent.
  In Illinois researchers regularly tell me how difficult it is to find 
government support for their medical research. They can spend as much 
time applying for grants and opening rejection letters as they do 
conducting experiments and analyzing data.
  There are indications that young researchers are taking their talents 
to other industries and even other countries. In 1982 18 percent of NIH 
primary investigators were under the age of 36. In 2011 3 percent of 
NIH primary investigators were under the age of 36. The young 
researchers aren't going in to government-sponsored research. 
Meanwhile, our population is aging, medical conditions from cancer to 
Alzheimer's are touching more and more lives, and the need for medical 
breakthroughs has never been greater.
  Back in Illinois I had the pleasure of visiting the lab of legendary 
researcher Dr. Janet Rowley at the University of Chicago. She was an 
inspiration. I wish I could have met her. Four decades ago, sitting at 
her dining room table in Hyde Park in Chicago, she had what she called 
an ``oh wow'' moment--a flash of insight that transformed the world's 
understanding of cancer. Until that moment it was generally assumed 
genetic abnormalities were the result of cancer. Dr. Rowley's work 
showed it was the other way around; that genetic mutations in fact 
caused cancer. That revolutionary insight led to targeted drug 
treatments for previously untreatable cancers. What family--what family 
on Earth--has not been touched by cancer?
  Janet Rowley was working under a small grant from the National 
Institutes of Health when she made this historic finding. One of the 
parts of her story I love is when she and her family returned to 
Chicago in 1962, Janet told the University of Chicago she would like to 
come back to continue her research with a couple of conditions. She 
said: I am a mother of four boys. I can only work part time. Second, 
she wanted a microscope, a desk, and a salary. She asked for $5,000 a 
year. To its everlasting credit, the University of Chicago said yes. 
Ten years later came her ``oh wow'' moment that changed our 
understanding of cancer.
  One of my deep concerns is this: How many other Janet Rowleys are 
being lost in America to medical research because they can't get the 
financial support for the grants they need to move forward? How many 
medical scientists have been forced to scale back or even abandon vital 
research because of ill-advised cuts to the National Institutes of 
Health?
  If America is going to remain a world leader in research that does 
contribute to longer and healthier lives, Federal funding for medical 
research has to be a national priority. Last week I reintroduced a 
critical bill. The American Cures Act calls for $150 billion in Federal 
research funding to support medical breakthroughs over the next 10 
years.
  I guarantee we will get more than $150 billion in payback if we put 
that money in medical research. If we can delay the onset of 
Alzheimer's in this country just by weeks or months, and God willing 
cure it, think of how much we will save. Last year it cost our Federal 
Government over $200 billion to treat Alzheimer's patients.
  For researchers making long-term plans, it is not only the amount of 
funding but its reliability. That is why the American Cures Act would 
eliminate the year-to-year unpredictability of congressional budgets 
and politics and set a steady growth rate of 5 percent over 10 years.
  Francis Collins, one of the most extraordinary doctors in America, 
heads up the NIH, and he said: This, Senator, will make a difference.
  These funds would go to four institutions: the National Institutes of 
Health, the Centers for Disease Control and Prevention, the Department 
of Defense health programs, and the VA Medical and Prosthetic Research 
Program.
  The American Cures Act will make funding for lifesaving medical 
research less political and more predictable.
  I thank my colleagues, Senators Sherrod Brown, Amy Klobuchar, Barbara 
Boxer, Ed Markey, Ben Cardin, Al Franken, Bob Casey, and Chuck Schumer, 
as well as Congresswoman Anna Eshoo for cosponsoring and sponsoring 
this legislation. People may have seen the old bumper sticker that 
said: If you think education is expensive, try ignorance. Well, if you 
think biomedical research is expensive, try illness.
  Medical research is a great investment. Every $1 we spend generates 
over $2 in economic growth. We more than double our investment and that 
is before counting the value of diseases cured.
  Dr. Anthony Fauci, a brilliant epidemiologist who heads the National 
Institutes of Allergy and Infectious Diseases, said of the discovery of 
teixobactin: ``That was a long shot--but it worked.''
  That was also true with the polio vaccine, discovered 60 years ago by 
Dr. Jonas Salk, and so many other American cures and breakthroughs that 
have changed the world. Private industry doesn't fund this sort of 
basic foundational science. It can't. This kind of science takes 
patience and time and a lot of investment.
  America is blessed with some of the best and most generous medical 
philanthropies in the world, but they can't fill this funding gap. Only 
we can do it. It takes our government to fund the science that leads to 
breakthrough cures. This shouldn't be a partisan issue, and it 
shouldn't be a low-budget priority. I think it should be the highest.
  I ask my colleagues to join me in supporting the American Cures Act 
to help save lives, restore biomedical research leadership, and 
strengthen America.

[[Page 1747]]

  As Jonas Salk, the pioneer of the polio vaccine, would say: ``The 
only way we can lose is if we stop too soon.''
  Mr. President, I yield the floor.
  I suggest the absence of a quorum.
  The PRESIDING OFFICER (Mr. Cotton). The clerk will call the roll.
  The assistant legislative clerk proceeded to call the roll.
  Mr. COCHRAN. Mr. President, I ask unanimous consent that the order 
for the quorum call be rescinded.
  The PRESIDING OFFICER. Without objection, it is so ordered.


  

                          ____________________